Selected research
Market Structure
Global Oligonucleotide Array Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Oligonucleotide Array market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Oligonucleotide Array is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Oligonucleotide Array is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Oligonucleotide Array is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Oligonucleotide Array is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Oligonucleotide Array include Illumnia, Affymetrix, Agilent Technologies, Roche NimbleGen, Sengenics, Arrayit, Applied Microarrays, Biometrix Technology and Savyon Diagnostics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
On the production side, the report examines Oligonucleotide Array output, growth rates, and market shares by manufacturer and by region (at regional and country level) for 2021-2026, with forecasts through 2032.
On the consumption side, the report analyzes sales of Oligonucleotide Array by region (regional and country level), company, type, and application for 2021-2026 and provides forecasts through 2032.
The report provides an overview of the global Oligonucleotide Array market in terms of capacity, output, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Oligonucleotide Array and consumption patterns in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Oligonucleotide Array sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by type and application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Oligonucleotide Array market size, projected growth trends, production technologies, key applications, and end-use industries.
Oligonucleotide Array Segment by Company
Illumnia
Affymetrix
Agilent Technologies
Roche NimbleGen
Sengenics
Arrayit
Applied Microarrays
Biometrix Technology
Savyon Diagnostics
Scienion AG
WaferGen
Oligonucleotide Array Segment by Type
Long Oligonucleotide Chip
Short Oligonucleotide Chip
Oligonucleotide Array Segment by Application
Gene Expression
Genotyping
Others
Oligonucleotide Array Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oligonucleotide Array market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Oligonucleotide Array and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oligonucleotide Array.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Oligonucleotide Array market, including product definition, global market growth prospects, production value, capacity, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Oligonucleotide Array industry.
Chapter 3: Detailed analysis of Oligonucleotide Array market competition landscape. Including Oligonucleotide Array manufacturers' output value, output and average price from 2021 to 2026, as well as competition analysis indicators such as origin, product type, application, merger and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 7: Production/Production Value of Oligonucleotide Array by region. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 8: Consumption of Oligonucleotide Array in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Long Oligonucleotide Chip
- Short Oligonucleotide Chip
Applications
- Gene Expression
- Genotyping
- Others
Companies covered
- Illumnia
- Affymetrix
- Agilent Technologies
- Roche NimbleGen
- Sengenics
- Arrayit
- Applied Microarrays
- Biometrix Technology
- Savyon Diagnostics
- Scienion AG
- WaferGen
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Oligonucleotide Array Production Value Estimates and Forecasts (2021-2032)
- 1.2.2 Global Oligonucleotide Array Production Capacity Estimates and Forecasts (2021-2032)
- 1.2.3 Global Oligonucleotide Array Production Estimates and Forecasts (2021-2032)
- 1.2.4 Global Oligonucleotide Array Market Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Global Oligonucleotide Array Market Dynamics
- 2.1 Oligonucleotide Array Industry Trends
- 2.2 Oligonucleotide Array Industry Drivers
- 2.3 Oligonucleotide Array Industry Opportunities and Challenges
- 2.4 Oligonucleotide Array Industry Restraints
3 Oligonucleotide Array Market by Manufacturers
- 3.1 Global Oligonucleotide Array Production Value by Manufacturers (2021-2026)
- 3.2 Global Oligonucleotide Array Production by Manufacturers (2021-2026)
- 3.3 Global Oligonucleotide Array Average Price by Manufacturers (2021-2026)
- 3.4 Global Oligonucleotide Array Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Oligonucleotide Array Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Oligonucleotide Array Manufacturers, Product Type & Application
- 3.7 Global Oligonucleotide Array Manufacturers Established Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Oligonucleotide Array Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Oligonucleotide Array Players Market Share by Production Value in 2025
- 3.8.3 2025 Oligonucleotide Array Tier 1, Tier 2, and Tier 3
4 Oligonucleotide Array Market by Type
- 4.1 Oligonucleotide Array Type Introduction
- 4.1.1 Long Oligonucleotide Chip
- 4.1.2 Short Oligonucleotide Chip
- 4.2 Global Oligonucleotide Array Production by Type
- 4.2.1 Global Oligonucleotide Array Production by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Oligonucleotide Array Production by Type (2021-2032)
- 4.2.3 Global Oligonucleotide Array Production Market Share by Type (2021-2032)
- 4.3 Global Oligonucleotide Array Production Value by Type
- 4.3.1 Global Oligonucleotide Array Production Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Oligonucleotide Array Production Value by Type (2021-2032)
- 4.3.3 Global Oligonucleotide Array Production Value Market Share by Type (2021-2032)
5 Oligonucleotide Array Market by Application
- 5.1 Oligonucleotide Array Application Introduction
- 5.1.1 Gene Expression
- 5.1.2 Genotyping
- 5.1.3 Others
- 5.2 Global Oligonucleotide Array Production by Application
- 5.2.1 Global Oligonucleotide Array Production by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Oligonucleotide Array Production by Application (2021-2032)
- 5.2.3 Global Oligonucleotide Array Production Market Share by Application (2021-2032)
- 5.3 Global Oligonucleotide Array Production Value by Application
- 5.3.1 Global Oligonucleotide Array Production Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Oligonucleotide Array Production Value by Application (2021-2032)
- 5.3.3 Global Oligonucleotide Array Production Value Market Share by Application (2021-2032)
6 Company Profiles
- 6.1 Illumnia
- 6.1.1 Illumnia Company Information
- 6.1.2 Illumnia Business Overview
- 6.1.3 Illumnia Oligonucleotide Array Production, Value and Gross Margin (2021-2026)
- 6.1.4 Illumnia Oligonucleotide Array Product Portfolio
- 6.1.5 Illumnia Recent Developments
- 6.2 Affymetrix
- 6.2.1 Affymetrix Company Information
- 6.2.2 Affymetrix Business Overview
- 6.2.3 Affymetrix Oligonucleotide Array Production, Value and Gross Margin (2021-2026)
- 6.2.4 Affymetrix Oligonucleotide Array Product Portfolio
- 6.2.5 Affymetrix Recent Developments
- 6.3 Agilent Technologies
- 6.3.1 Agilent Technologies Company Information
- 6.3.2 Agilent Technologies Business Overview
- 6.3.3 Agilent Technologies Oligonucleotide Array Production, Value and Gross Margin (2021-2026)
- 6.3.4 Agilent Technologies Oligonucleotide Array Product Portfolio
- 6.3.5 Agilent Technologies Recent Developments
- 6.4 Roche NimbleGen
- 6.4.1 Roche NimbleGen Company Information
- 6.4.2 Roche NimbleGen Business Overview
- 6.4.3 Roche NimbleGen Oligonucleotide Array Production, Value and Gross Margin (2021-2026)
- 6.4.4 Roche NimbleGen Oligonucleotide Array Product Portfolio
- 6.4.5 Roche NimbleGen Recent Developments
- 6.5 Sengenics
- 6.5.1 Sengenics Company Information
- 6.5.2 Sengenics Business Overview
- 6.5.3 Sengenics Oligonucleotide Array Production, Value and Gross Margin (2021-2026)
- 6.5.4 Sengenics Oligonucleotide Array Product Portfolio
- 6.5.5 Sengenics Recent Developments
- 6.6 Arrayit
- 6.6.1 Arrayit Company Information
- 6.6.2 Arrayit Business Overview
- 6.6.3 Arrayit Oligonucleotide Array Production, Value and Gross Margin (2021-2026)
- 6.6.4 Arrayit Oligonucleotide Array Product Portfolio
- 6.6.5 Arrayit Recent Developments
- 6.7 Applied Microarrays
- 6.7.1 Applied Microarrays Company Information
- 6.7.2 Applied Microarrays Business Overview
- 6.7.3 Applied Microarrays Oligonucleotide Array Production, Value and Gross Margin (2021-2026)
- 6.7.4 Applied Microarrays Oligonucleotide Array Product Portfolio
- 6.7.5 Applied Microarrays Recent Developments
- 6.8 Biometrix Technology
- 6.8.1 Biometrix Technology Company Information
- 6.8.2 Biometrix Technology Business Overview
- 6.8.3 Biometrix Technology Oligonucleotide Array Production, Value and Gross Margin (2021-2026)
- 6.8.4 Biometrix Technology Oligonucleotide Array Product Portfolio
- 6.8.5 Biometrix Technology Recent Developments
- 6.9 Savyon Diagnostics
- 6.9.1 Savyon Diagnostics Company Information
- 6.9.2 Savyon Diagnostics Business Overview
- 6.9.3 Savyon Diagnostics Oligonucleotide Array Production, Value and Gross Margin (2021-2026)
- 6.9.4 Savyon Diagnostics Oligonucleotide Array Product Portfolio
- 6.9.5 Savyon Diagnostics Recent Developments
- 6.10 Scienion AG
- 6.10.1 Scienion AG Company Information
- 6.10.2 Scienion AG Business Overview
- 6.10.3 Scienion AG Oligonucleotide Array Production, Value and Gross Margin (2021-2026)
- 6.10.4 Scienion AG Oligonucleotide Array Product Portfolio
- 6.10.5 Scienion AG Recent Developments
- 6.11 WaferGen
- 6.11.1 WaferGen Company Information
- 6.11.2 WaferGen Business Overview
- 6.11.3 WaferGen Oligonucleotide Array Production, Value and Gross Margin (2021-2026)
- 6.11.4 WaferGen Oligonucleotide Array Product Portfolio
- 6.11.5 WaferGen Recent Developments
7 Global Oligonucleotide Array Production by Region
- 7.1 Global Oligonucleotide Array Production by Region: 2021 VS 2025 VS 2032
- 7.2 Global Oligonucleotide Array Production by Region (2021-2032)
- 7.2.1 Global Oligonucleotide Array Production by Region (2021-2026)
- 7.2.2 Global Oligonucleotide Array Production Forecast by Region (2027-2032)
- 7.3 Global Oligonucleotide Array Production by Region: 2021 VS 2025 VS 2032
- 7.4 Global Oligonucleotide Array Production Value by Region (2021-2032)
- 7.4.1 Global Oligonucleotide Array Production Value by Region (2021-2026)
- 7.4.2 Global Oligonucleotide Array Production Value by Region (2027-2032)
- 7.5 Global Oligonucleotide Array Market Price Analysis by Region (2021-2032)
- 7.6 Regional Production Value Trends (2021-2032)
- 7.6.1 North America Oligonucleotide Array Production Value (2021-2032)
- 7.6.2 Europe Oligonucleotide Array Production Value (2021-2032)
- 7.6.3 Asia-Pacific Oligonucleotide Array Production Value (2021-2032)
- 7.6.4 South America Oligonucleotide Array Production Value (2021-2032)
- 7.6.5 Middle East & Africa Oligonucleotide Array Production Value (2021-2032)
8 Global Oligonucleotide Array Consumption by Region
- 8.1 Global Oligonucleotide Array Consumption by Region: 2021 VS 2025 VS 2032
- 8.2 Global Oligonucleotide Array Consumption by Region (2021-2032)
- 8.2.1 Global Oligonucleotide Array Consumption by Region (2021-2026)
- 8.2.2 Global Oligonucleotide Array Consumption by Region (2027-2032)
- 8.3 North America
- 8.3.1 North America Oligonucleotide Array Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3.2 North America Oligonucleotide Array Consumption by Country (2021-2032)
- 8.3.3 U.S.
- 8.3.4 Canada
- 8.3.5 Mexico
- 8.4 Europe
- 8.4.1 Europe Oligonucleotide Array Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.4.2 Europe Oligonucleotide Array Consumption by Country (2021-2032)
- 8.4.3 Germany
- 8.4.4 France
- 8.4.5 U.K.
- 8.4.6 Italy
- 8.4.7 Netherlands
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Oligonucleotide Array Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.5.2 Asia Pacific Oligonucleotide Array Consumption by Country (2021-2032)
- 8.5.3 China
- 8.5.4 Japan
- 8.5.5 South Korea
- 8.5.6 Southeast Asia
- 8.5.7 India
- 8.5.8 Australia
- 8.6 South America
- 8.6.1 South America Oligonucleotide Array Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.6.2 South America Oligonucleotide Array Consumption by Country (2021-2032)
- 8.6.3 Brazil
- 8.6.4 Argentina
- 8.6.5 Chile
- 8.6.6 Colombia
- 8.7 Middle East & Africa
- 8.7.1 Middle East & Africa Oligonucleotide Array Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.7.2 Middle East & Africa Oligonucleotide Array Consumption by Country (2021-2032)
- 8.7.3 Egypt
- 8.7.4 South Africa
- 8.7.5 Israel
- 8.7.6 Türkiye
- 8.7.7 GCC Countries
9 Value Chain and Sales Channels Analysis
- 9.1 Oligonucleotide Array Value Chain Analysis
- 9.1.1 Oligonucleotide Array Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Oligonucleotide Array Production Mode & Process
- 9.2 Oligonucleotide Array Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Oligonucleotide Array Distributors
- 9.2.3 Oligonucleotide Array Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst